DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Smith MR, Saad F, Chowdhury S. et al.
843OApalutamide (APA) and overall survival (OS) in patients (pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC): Updated results from the phase III SPARTAN study.
Ann Oncol 2019;
30
DOI: 10.1093/annonc/mdz248.
We do not assume any responsibility for the contents of the web pages of other providers.